IBM stock price is trading near $258 with a Buy consensus from 34 analysts and a median $340 price target — risk/reward favours bulls, with 16% near-term upside to RBC’s $300 target and 32% upside to the consensus median. The setup is anchored by Q1 FY26 revenue of $15.9 billion (+9% YoY), Software revenue of $7.05 billion (+11% YoY), Red Hat OpenShift reaching a $2 billion ARR run-rate, and the May 2026 announcement of the Anderon quantum foundry — a $2 billion joint commitment between IBM ($1B cash plus IP) and the U.S. Department of Commerce ($1B CHIPS Act funding) that positions IBM at the heart of U.S. quantum manufacturing through 2029.
| Key Stock Data | Value |
|---|---|
| Current Price | ~$258 |
| 52-Week Range | $195 – $290 |
| Market Cap | ~$240 billion |
| P/E (TTM) | ~28x |
| Q1 FY26 Revenue | $15.9 billion (+9% YoY) |
| Q1 FY26 Non-GAAP EPS | $1.91 (beat $1.81 est.) |
| Dividend Yield | ~2.6% |
| Analyst Consensus | Buy (34 analysts) |
| Average Price Target | $294.41 |
| High / Low / Median | $400 / $200 / $340 |
Table of Contents
- IBM Stock Snapshot — Key Takeaways
- What IBM Does and Why IBM Stock Price Matters
- IBM Stock Price Recent Performance
- IBM Stock Price Valuation Analysis
- Q1 FY26 Earnings, Software, and the IBM Stock Thesis
- The Anderon Quantum Foundry and the IBM Stock 2029 Bet
- Bullish and Bearish Analyst Opinions on International Business Machines
- IBM Stock Analyst Price Targets and 12-Month Outlook
- How to Trade IBM Stock via MEXC
- IBM Stock Risks Investors Should Not Ignore
- IBM Stock Price FAQs
IBM Stock Snapshot — Key Takeaways
- Price and verdict: IBM stock price trades near $258 with a Buy consensus, $294 average target, and $340 median target — risk/reward favours bulls into the AI-monetisation cycle.
- Key stat: Software revenue grew 11% to $7.05 billion in Q1 FY26, with Red Hat OpenShift reaching $2B ARR and growing in the high 20% range; non-GAAP EPS of $1.91 beat consensus by 5.5%.
- Bull case: RBC $300 target, generative AI book of business $7.5–8.5 billion inception-to-date with two-thirds flowing through consulting, watsonx adoption acceleration, and the $2B Anderon quantum foundry partnership.
- Bear case: Hyperscaler competition in cloud, mainframe revenue cyclicality, ~$55 billion gross debt load, and lingering questions about AI margin pull-through versus consulting commoditisation.
- What to watch: Q2 FY26 print (expected July 2026), Red Hat ARR cadence, AI book-of-business updates, and Anderon foundry execution milestones.
What IBM Does and Why IBM Stock Price Matters
International Business Machines (NYSE: IBM) operates a global enterprise technology business across four reporting segments: Software (Red Hat, automation, data, AI), Consulting (strategy, AI delivery, business transformation), Infrastructure (zSystems mainframes, storage, distributed infrastructure), and Financing. The 2019 Red Hat acquisition repositioned IBM as the hybrid-cloud platform leader, and the 2024–2026 watsonx and AI-services expansion is the company’s bid to capture enterprise AI deployment spend.
The reason IBM stock price matters in 2026 is that the company is now genuinely two businesses sharing one ticker. The legacy “old IBM” — mainframes, traditional services, dividends — continues to generate the cash flow that supports the 2.6% yield and the buyback program. The “new IBM” — Red Hat, watsonx, the Anderon quantum foundry, and the generative AI consulting book — is finally producing visible top-line acceleration. Investors aren’t just paying for a tech utility anymore; they are paying for participation in the AI infrastructure cycle alongside Microsoft stock price, Oracle stock price, and the hyperscalers.
IBM stock price offers a balance no pure-play AI name provides: 2.5%+ dividend yield, investment-grade balance sheet, +9% Q1 revenue growth, and AI exposure through a high-touch enterprise channel rather than commoditised compute. Versus peers like ServiceNow stock price and Snowflake stock price, IBM’s income profile and AI consulting moat differentiate the risk-adjusted return.
IBM Stock Price Recent Performance
IBM stock price has been one of the megacap success stories of 2026. Shares are up 128% from the 2024 trough and have outperformed the broader software cohort meaningfully on a 12-month basis. The Q1 FY26 earnings release on April 22 added another leg as Software growth of 11% and the EPS beat removed concerns that AI consulting margin was decelerating.
The May rally accelerated after the Anderon foundry announcement. The market read the $1B IBM commitment plus $1B CHIPS funding as a derisked path to quantum commercialisation rather than a speculative spend, and the stock has held the gains through the rest of the month. Implied volatility remains low relative to other AI-exposed names, reflecting the dividend cushion and the diversification of the revenue base.
Technically, IBM stock price has cleared $245 resistance and is testing $260. A break above $270 puts the $290 52-week high in play, with the $300 RBC target shortly after. The 50-day average at $247 now acts as first major support.
Volume profile shows accumulation through the post-Q1 base in late April. Institutional flows are net positive year-to-date as active managers re-engage after years of relative underweight — the dividend cushion plus AI growth combination has finally produced the rotation bulls awaited.
IBM Stock Price Valuation Analysis
Valuing IBM stock price requires balancing two perspectives: the cash-flow-rich legacy business and the higher-multiple software and AI growth components. On a blended basis, the stock trades at roughly 28x trailing earnings and 22x forward earnings — premium to the company’s 10-year average but discount to high-growth software peers.
| Metric | IBM | Peers / Index | Read-through |
|---|---|---|---|
| Forward P/E | ~22x | 28x (software avg) | Discount to software cohort, premium to value cohort |
| EV / Sales | ~3.5x | 5–10x | Still cheap on revenue multiples |
| Dividend Yield | ~2.6% | 0.5% (software avg) | Income kicker no pure-play AI name offers |
| FY26 Revenue Growth | ~6–7% | 15–25% (high-growth SW) | Slower but accelerating |
| SWS Narrative Fair Value | $302.05 | — | 20% upside from current |
The bull math: assume Software grows at 11–12% sustained (Red Hat in the high teens, watsonx accelerating), Consulting accelerates to mid-single digits as the AI backlog converts, and Infrastructure stays flat with a mainframe-refresh tailwind through 2027. That blend produces ~$10.5 billion in earnings by 2028 versus $5.9 billion today — the Simply Wall St narrative target of $302.05 (20% upside) is built on exactly that path.
The bear math: assume mainframe demand normalises post-refresh cycle, AI consulting margin compresses as competitors copy IBM’s offerings, and rising compliance costs erode operating leverage. That scenario lands closer to $7.5–8 billion in earnings and a fair value in the $230–$250 zone — meaning even the bear case carries limited downside from the current $258 print. That asymmetry is what makes the risk/reward favour bulls.
Q1 FY26 Earnings, Software, and the IBM Stock Thesis
The April 22, 2026 Q1 FY26 print was a clean validation of the bull thesis. Revenue of $15.9 billion grew 9% year-over-year as reported and 6% at constant currency, beating the Wall Street consensus of $15.8 billion. Non-GAAP operating EPS of $1.91 grew 19% year-over-year and beat the $1.81 consensus.
Segment-level performance was even more constructive. Software revenue grew 11% to $7.05 billion, with Red Hat continuing to lead at low-teens growth and Red Hat OpenShift specifically reaching a $2 billion ARR run-rate with high-20% growth. Consulting revenue of $5.27 billion grew 4%, and management guided to low-to-mid-single-digit acceleration through the rest of FY26 as the generative AI backlog converts. The book of business for generative AI crossed $7 billion in Q4 2025 and is now widely modeled at $7.5–8.5 billion as of Q1 2026, with roughly two-thirds flowing through Consulting and one-third through Software.
Cash generation remained best-in-class. Free cash flow conversion stayed above 90%, the dividend was reaffirmed, and the buyback was active. Management raised the full-year free cash flow outlook modestly, signalling confidence that the AI backlog would translate to bottom-line earnings on the planned timeline.
The investment implication: every Q1 data point reinforces the assertive Buy framing. Software growth is real and accelerating, AI bookings are converting to revenue at the modeled cadence, and the legacy cash flow base continues to fund the dividend and buyback. For IBM stock price holders, the next gating event is the Q2 FY26 print expected in late July, where the bull case requires continued Software acceleration and tangible evidence the consulting AI backlog is shipping at the modeled margin.
The Anderon Quantum Foundry and the IBM Stock 2029 Bet
The May 2026 announcement of Anderon was a structurally important moment for IBM stock price. IBM and the U.S. Department of Commerce signed a Letter of Intent to create a standalone quantum chip foundry in Albany, New York, backed by $1 billion in CHIPS Act incentives and $1 billion of IBM cash plus intellectual property and talent contributions.
The strategic significance is double-edged. First, Anderon positions IBM as the supplier of choice for U.S. quantum hardware vendors, expanding the addressable market beyond IBM’s own quantum systems. Second, the explicit CHIPS Act backing reduces the political and economic risk of the multi-year build-out — the federal government is effectively co-underwriting the foundry’s commercial viability. The target of supplying wafers for large-scale, fault-tolerant quantum computers by 2029 is ambitious but no longer purely speculative.
For 2026–2027 investors, the Anderon announcement matters less as a near-term earnings catalyst and more as evidence that IBM has secured a defensible position in the next computing paradigm. Quantum revenue will be immaterial in 2026 and 2027; what matters is that bulls can now point to a tangible 2029+ optionality without relying purely on management commentary. That kind of derisking is what justifies the recent multiple expansion.
Bullish and Bearish Analyst Opinions on International Business Machines
Wall Street has converged on a Buy consensus for IBM stock price, with 11 Buy, 7 Hold, and 3 Sell ratings across the 34-analyst panel. The median price target of $340 implies meaningful upside, though the dispersion between the low ($200) and high ($400) signals that analysts disagree sharply on how much credit to extend for AI conversion and quantum optionality.
| Theme | Bullish View | Bearish View |
|---|---|---|
| AI bookings | $7.5–8.5B AI book of business; 30% backlog penetration | Consulting AI margin sustainability questioned |
| Software momentum | Red Hat OpenShift $2B ARR; Software +11% YoY | Hyperscaler competition continues to intensify |
| Quantum optionality | $2B Anderon foundry; 2029 fault-tolerant target | Quantum revenue immaterial for at least 2 years |
| Cash returns | 2.6% dividend yield; active buyback | ~$55B gross debt limits financial flexibility |
| Targets | RBC $300; median $340; high $400 | Low $200 target implies 22% downside |
The most-cited bull is RBC Capital, which raised its IBM stock price target to $300 (16.31% upside) on May 6, 2026, citing the AI backlog conversion path and the sustained Software acceleration. Goldman Sachs and Morgan Stanley remain Buy-rated and have published target updates in the $310–$340 zone. Bank of America’s note highlighted the combination of dividend yield, AI optionality, and quantum derisking as the rare “barbell” thesis available in mega-cap tech.
The most-cited bear case rests on competitive dynamics. Skeptics point to ongoing hyperscaler share gains in cloud workloads, the risk that AI consulting becomes commoditised by 2027, and IBM’s $55 billion gross debt load that constrains capital flexibility relative to net-cash competitors. The $200 low target reflects a scenario where Software growth decelerates to mid-single digits and Consulting margin compresses.
IBM Stock Analyst Price Targets and 12-Month Outlook
The IBM stock price 12-month consensus target sits at $294.41 across 21 S&P Global panel analysts, with the broader 34-analyst panel producing a median target of $340. RBC’s $300 (May 6) is the most recent published note and the cleanest articulation of the near-term bull setup.
| Firm | Rating | Price Target | Implied Move |
|---|---|---|---|
| Wall Street high | Buy | $400 | +55% |
| 34-analyst median | Buy | $340 | +32% |
| RBC Capital (May 6) | Outperform | $300 | +16% |
| Consensus (21 analysts) | Buy | $294.41 | +14% |
| Wall Street low | Sell | $200 | -22% |
Our IBM stock price analysis framework arrives at $310 as the central 12-month estimate, $340–$360 in a scenario where AI consulting margins exceed plan, and $230–$240 in a scenario where mainframe revenue softens materially. The current $258 print prices in a moderate version of the bull case — enough upside to justify holding, plenty more to be earned if execution accelerates.
How to Trade IBM Stock via MEXC
MEXC offers a tokenized version of IBM shares that allows crypto-native investors to gain IBM stock price exposure 24/7 — no US brokerage account required, settled in USDT, and trading continues even when US markets are closed. The pair tracks the underlying IBM equity, so investors can react to Anderon foundry milestones, AI backlog disclosures, or quarterly print reactions in real time. Access the IBM USDT exchange to trade IBM 24/7 as a tokenized stock on MEXC, no US broker needed.
IBM Stock Risks Investors Should Not Ignore
Three risk vectors deserve specific attention before sizing positions in IBM stock price. First, hyperscaler competition. Microsoft Azure, AWS, and Google Cloud continue to capture cloud workload share, and any acceleration of hyperscaler-native AI offerings would compress Red Hat’s growth corridor and pressure consulting differentiation.
Second, debt and capital allocation. IBM carries approximately $55 billion in gross debt and roughly $48 billion net of cash. The balance sheet is investment-grade and the interest coverage is healthy, but the leverage limits IBM’s ability to compete with net-cash competitors on M&A or step-function capex. Rising compliance and regulatory costs add a structural headwind.
Third, AI execution risk. The $7.5–8.5 billion generative AI book of business is impressive, but the conversion to recognised revenue is multi-quarter and depends on enterprise deployment timelines IBM does not fully control. Any slippage in backlog conversion would compress the IBM stock price re-rating thesis and re-open the bear-case multiple compression scenario.
IBM Stock Price FAQs
Is IBM stock a buy in 2026?
The risk/reward favours bulls. With a Buy consensus across 34 analysts, RBC’s $300 target implying 16% upside, a $340 median target implying 32% upside, and a 2.6% dividend yield cushioning the wait, IBM stock price offers the rare combination of income, growth, and quantum optionality. Sizing should reflect that the path to $300+ requires continued Software acceleration and consulting AI conversion — both visible but not yet fully de-risked.
What is the bullish and bearish analyst opinion on IBM?
Bulls (RBC $300, median $340 across 34 analysts) cite the $7.5–8.5B AI book of business, Red Hat OpenShift’s $2B ARR, the $2B Anderon quantum foundry partnership, and the 2.6% dividend yield. Bears (low target $200) flag hyperscaler competition, the $55B gross debt load, and the risk that consulting AI margin compresses as competitors copy IBM’s offerings. The vote stands at 11 Buy / 7 Hold / 3 Sell.
What is IBM’s price target for 2026?
The 12-month consensus IBM stock price target is $294.41 across 21 analysts (S&P Global panel), with a broader 34-analyst median of $340. The high target is $400, the low is $200, and the realistic 12-month band is $280–$340. RBC’s $300 target published May 6, 2026 represents the cleanest recent published note.
What is the Anderon quantum foundry and how does it affect IBM stock?
Anderon is a standalone quantum chip foundry being built in Albany, New York under a $1B CHIPS Act commitment plus $1B IBM cash and IP. The strategic significance is that IBM becomes the supplier of choice for U.S. quantum hardware vendors with federal-backed risk mitigation. Quantum revenue will be immaterial in 2026–2027; the value lies in the 2029+ optionality which now feels more derisked than purely speculative.
How can I trade IBM stock outside US market hours?
MEXC offers a tokenized version of IBM shares (IBMON_USDT) that lets you gain IBM stock price exposure 24/7 settled in USDT, with no need for a US brokerage account. The tokenized pair tracks the underlying IBM equity in real time and is particularly useful for reacting to overnight news on Anderon foundry milestones, AI consulting wins, or pre-market reactions to peer earnings.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.